Panupong Chaowanasawat is an Associate at the Health Intervention and Technology Assessment Program (HITAP). He holds a Bachelor of Science in Public Health (Honors) with a minor in Global Health and Social Medicine from Wayne State University, USA. His academic and professional background reflects a strong commitment to public health research and

Chayapat Rachatan is currently a Project Associate at HITAP. She supports the HTA and health system research. Her research studies focus on COVID-19 policy research and decision support, effectiveness evaluation of COVID-19 vaccine chatbot, cost analysis of governance system in health sector, situational analysis of infectious disease modelling in

Budsadee Soboon position research assistant. She graduated a bachelor’s degree in clinical pharmacy from Srinakharinwirot University, with passion to search for information, analyze the data and are interested in assessing the cost-effectiveness of medicine selection for patients. She hopes to apply her knowledge and over 12 years of experience in

As innovative technologies and biological treatment are becoming available for use, policymakers worldwide will require a tool to evaluate the cost and assess the trade-offs. The concept of Total System Effectiveness (TSE) is an end-to-end analytical framework which is intended to inform future inve

The Ministry of Health (MoH), Bhutan has developed a health technology assessment (HTA) program in Bhutan since 2013 and has continued its efforts to build HTA capacity and maintain its momentum. This year, the MoH shows interest and is seeking support on: • Cost-effectiveness threshold led by th

In October 2018, three researchers from the Christian Medical College (CMC) Vellore spent a week at the Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand, to learn about health technology assessments and to apply costing analyses on two cost-ofillness

In early 2019, the Philippines passed a Universal Health Coverage (UHC) Act that automatically enrolls all Filipino citizens in a national health insurance scheme under the Philippine Health Insurance Corporation (PhilHealth). P0F0F1 P Their aim, to improve the breadth and depth of healthcare cove

This report summarizes the sessions in the Medicines Pricing, Reimbursement Policy, and Benefits Package for Medicines in Thailand study visit, held on 4 – 8 March 2024 in Nonthaburi, Thailand. This study visit was organized by the Health Intervention and Technology Assessment Program (HITAP) under

Economic evaluation of treatment administration strategies of ganciclovir for cytomegalovirus retinitis in HIV/AIDS patients in Thailand: a simulation study. Teerawattananon K1, Iewsakul S1, Yenjitr C2, Ausayakhun S3, Yenjitr W4, Mugford M5, Teerawattananon Y2,6. 1 Ophthalmology Unit, Chiangkh

A Systematic Review of Economic Evaluation Literature in Thailand. Are the Data Good Enough to be Used by Policy-Makers? Yot Teerawattananon1 Steve Russell2 Miranda Mugford3 1 International Health Policy Program, MInistry of Public Health, Nonthaburi, Thailand 2 School of Development Studie